Article
Multidisciplinary Sciences
Bindu D. Paul, Marian D. Lemle, Anthony L. Komaroff, Solomon H. Snyder
Summary: The review summarizes evidence of biological abnormalities in patients with acute COVID-19 and ME/CFS, including redox imbalance, systemic inflammation, neuroinflammation, impaired ATP generation, and general hypometabolism. Although these phenomena have not been extensively studied in individuals with long COVID-19, understanding these abnormalities may lead to the development of novel therapeutics.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2021)
Review
Clinical Neurology
Todd Nelson, Lan-Xin Zhang, Hui Guo, Luis Nacul, Xiaowei Song
Summary: Recent MRI studies have shown structural changes in the white and gray matter of ME/CFS patients, as well as abnormal functional connectivity within the brainstem and with other brain regions. Possible mechanisms including astrocyte dysfunction, cerebral perfusion impairment, impaired nerve conduction, and neuroinflammation in the brainstem may explain the heterogeneous presentations of symptoms in individual patients.
FRONTIERS IN NEUROLOGY
(2021)
Review
Multidisciplinary Sciences
Olga A. Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, SabbaRao V. Madhunapantula, Mikhail Sinelnikov, Vladimir N. Nikolenko, Margarita E. Neganova, Sergey G. Klochkov, Mohammad Amjad Kamal, Donald R. Staines, Sonya Marshall-Gradisnik
Summary: COVID-19 infection can lead to various pathologies and complications, exacerbating existing conditions in multiple body systems. Besides the respiratory organs, adverse effects of COVID-19 have been observed in the nervous, cardiovascular, gastrointestinal/metabolic, immune, and other systems. The post-COVID-19 condition shows overlapping symptoms with ME/CFS.
JOURNAL OF ADVANCED RESEARCH
(2022)
Article
Medicine, General & Internal
Pamela G. Mckay, Helen Walker, Colin R. Martin, Mick Fleming
Summary: The study found no significant differences in symptom experience between chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia. Structural equation modeling showed similar experiences between the two groups.
Review
Medicine, General & Internal
Rebekah Maksoud, Chandi Magawa, Natalie Eaton-Fitch, Kiran Thapaliya, Sonya Marshall-Gradisnik
Summary: This systematic review aimed to evaluate potential biomarkers that could effectively differentiate ME/CFS patients from healthy controls. A total of 101 studies were included, and potential biomarkers ranged from genetic/epigenetic, immunological, metabolomics/mitochondrial/microbiome, endovascular/circulatory, neurological, ion channel, to physical dysfunction biomarkers. The findings indicated evidence of immune dysfunction in ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of the illness.
Article
Ophthalmology
Victor Sanchez, Colin K. Kim, Elyana V. T. Locatelli, Adam K. Cohen, Kimberly Cabrera, Kristina Aenlle, Nancy G. Klimas, Robert O'Brien, Anat Galor
Summary: Individuals with ME/CFS report increased ocular pain but similar dry eye symptoms.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Irene Soffritti, Sabine Gravelsina, Maria D'Accolti, Francesca Bini, Eleonora Mazziga, Anda Vilmane, Santa Rasa-Dzelzkaleja, Zaiga Nora-Krukle, Angelika Krumina, Modra Murovska, Elisabetta Caselli
Summary: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease without diagnostic biomarkers, but there is evidence supporting a role of herpesviruses and microRNAs in its development. This study found that six out of eight selected microRNAs were differently expressed in ME/CFS patients compared to healthy controls. The levels of these microRNAs correlated with disease severity but not with pro-inflammatory cytokines or HHV-6A/6B genome levels. These results suggest that microRNAs could serve as potential biomarkers and provide insights into ME/CFS pathogenic mechanisms.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Medicine, General & Internal
Nour Shaheen, Ahmed Shaheen
Summary: This study aims to understand the long-term symptoms of COVID-19 and explore the potential association with chronic fatigue syndrome/myalgic encephalomyelitis.
Review
Medicine, Research & Experimental
Rebekah Maksoud, Cassandra Balinas, Sean Holden, Helene Cabanas, Donald Staines, Sonya Marshall-Gradisnik
Summary: There is currently insufficient evidence on the effectiveness of mitochondrial-targeting nutraceuticals in treating ME/CFS patients. Future well-designed studies are needed to clarify the involvement of mitochondria in the pathomechanism of ME/CFS and the impact of mitochondrial-modifying agents on illness severity.
JOURNAL OF TRANSLATIONAL MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Varvara A. A. Ryabkova, Natalia Y. Y. Gavrilova, Alina A. A. Poletaeva, Alexander I. I. Pukhalenko, Irina A. A. Koshkina, Leonid P. P. Churilov, Yehuda Shoenfeld
Summary: Recent studies suggest that antibody-mediated autoimmune mechanisms may play a role in fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), specifically in relation to G protein-coupled receptors. However, the full extent of the natural antibody network and its implications in these disorders has not been fully explored.
Article
Neurosciences
J. Antonio Gonzalez-Hermosillo, Jhanea Patricia Martinez-Lopez, Sofia Antonieta Carrillo-Lampon, Dayanara Ruiz-Ojeda, Sharon Herrera-Ramirez, Luis M. Amezcua-Guerra, Maria del Rocio Martinez-Alvarado
Summary: The study found that fatigue was the most common symptom among COVID-19 recovered adults, with those aged 40 to 50 years being more likely to experience fatigue. Only 13% of patients met the criteria for ME/CFS.
Article
Immunology
Leonard A. Jason, Joseph Cotler, Mohammed F. Islam, Madison Sunnquist, Ben Z. Katz
Summary: This study investigated potential predictors of developing chronic fatigue syndrome (ME/CFS) in university students six months after developing infectious mononucleosis (IM). The research found that ME/CFS patients had more physical symptoms and immune irregularities before onset, but no significant differences in psychological symptoms compared to those who recovered.
CLINICAL INFECTIOUS DISEASES
(2021)
Review
Medicine, Research & Experimental
Manuel Ruiz-Pablos, Bruno Paiva, Aintzane Zabaleta
Summary: Both myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID (LC) share similar immunological alterations, chronic viral infection, autoimmunity, inflammation, viral reactivation, hypocortisolism, and microclot formation. They also have similar symptoms including fatigue, exercise intolerance, sleep disorders, cognitive dysfunction, and neurological and gastrointestinal complaints. Furthermore, both diseases show Epstein-Barr virus (EBV) reactivation, suggesting a potential link between them.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Medicine, Research & Experimental
Ludovic Giloteaux, Jiayin Li, Mady Hornig, W. Ian Lipkin, David Ruppert, Maureen R. R. Hanson
Summary: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex disease characterized by unexplained fatigue and other symptoms. This study found increased levels of extracellular vesicles (EVs) and IL2 cytokine in plasma of ME/CFS patients. The correlations between specific proteins and clinical data suggest immune response and hemostasis dysfunctions in ME/CFS.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Medicine, General & Internal
C. (Linda) M. C. van Campen, Peter C. Rowe, Freek W. A. Verheugt, Frans C. Visser
Summary: Muscle pain, fatigue, and concentration problems are common symptoms among individuals with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). This study found that orthostatic stress is an important determinant of postexertional malaise (PEM) in ME/CFS patients, as indicated by significantly increased numeric rating scales (NRS) for pain, fatigue, and concentration even at 7 days post head-up tilt testing (HUT).
FRONTIERS IN MEDICINE
(2021)
Article
Neurosciences
Kiran Thapaliya, Donald Staines, Sonya Marshall-Gradisnik, Jiasheng Su, Leighton Barnden
Summary: This study found that hippocampal subfield volumes are associated with cognitive and memory problems in ME/CFSICC patients, but not in ME/CFSFukuda patients. ME/CFSICC patients have larger subfield volumes, which are strongly correlated with clinical measures.
JOURNAL OF NEUROSCIENCE RESEARCH
(2022)
Article
Neurosciences
Kiran Thapaliya, Sonya Marshall-Gradisnik, Donald Staines, Jiasheng Su, Leighton Barnden
Summary: This study investigates cortical volumetric and thickness changes in Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) patients and healthy controls, revealing differences and abnormal correlations with key symptoms in ME/CFS patients.
FRONTIERS IN NEUROSCIENCE
(2022)
Article
Biochemistry & Molecular Biology
Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, Peter Smith, Olivia Ly Lesslar, Gary Deed, Sonya Marshall-Gradisnik
Summary: This study found that patients with post COVID-19 condition may have impaired TRPM3 ion channel function and similarities with ME/CFS.
MOLECULAR MEDICINE
(2022)
Editorial Material
Multidisciplinary Sciences
Sonya Marshall-Gradisnik, Natalie Eaton-Fitch
Article
Physiology
Chandi T. T. Magawa, Natalie Eaton-Fitch, Cassandra Balinas, Etianne Martini Sasso, Kiran Thapaliya, Leighton Barnden, Rebekah Maksoud, Breanna Weigel, Penny A. Rudd, Lara J. J. Herrero, Sonya Marshall-Gradisnik
Summary: The study aimed to optimize a high-yield protein extraction method for membrane proteins from NK cells, successfully detecting proteotypic peptides of TRPM3 for future investigations.
FRONTIERS IN PHYSIOLOGY
(2022)
Article
Neurosciences
Jiasheng Su, Kiran Thapaliya, Natalie Eaton-Fitch, Sonya Marshall-Gradisnik, Leighton Barnden
Summary: This study used functional magnetic resonance imaging to compare the connectivity patterns in the brains of healthy individuals and patients with chronic fatigue syndrome. The results showed significant differences in connectivity between the two groups, indicating that these differences may play a role in the development of chronic fatigue syndrome.
BRAIN CONNECTIVITY
(2023)
Review
Medicine, General & Internal
Rebekah Maksoud, Chandi Magawa, Natalie Eaton-Fitch, Kiran Thapaliya, Sonya Marshall-Gradisnik
Summary: This systematic review aimed to evaluate potential biomarkers that could effectively differentiate ME/CFS patients from healthy controls. A total of 101 studies were included, and potential biomarkers ranged from genetic/epigenetic, immunological, metabolomics/mitochondrial/microbiome, endovascular/circulatory, neurological, ion channel, to physical dysfunction biomarkers. The findings indicated evidence of immune dysfunction in ME/CFS and the use of lymphocytes as a model to investigate the pathomechanism of the illness.
Article
Neurosciences
Leighton Barnden, Kiran Thapaliya, Natalie Eaton-Fitch, Markus Barth, Sonya Marshall-Gradisnik
Summary: This study compared the brain connectivity in Long-Covid patients and healthy controls using functional magnetic resonance imaging (fMRI). It found differences in connectivity in the brainstem regions of Long-Covid patients, which may be related to their clinical symptoms.
FRONTIERS IN NEUROSCIENCE
(2023)
Review
Medicine, Research & Experimental
Asher Taccori, Rebekah Maksoud, Natalie Eaton-Fitch, Maharshi Patel, Sonya Marshall-Gradisnik
Summary: This systematic review aimed to evaluate and summarize the use of urinary biomarkers in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) compared to healthy controls. The study found significant differences in urinary free cortisol levels between ME/CFS patients and healthy controls, although there was considerable heterogeneity in the results. There is limited evidence suggesting a consistent and specific urinary-based biomarker for ME/CFS, and further standardized research is needed to identify potential diagnostic differences.
JOURNAL OF TRANSLATIONAL MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Stanley Du Preez, Natalie Eaton-Fitch, Peter K. Smith, Sonya Marshall-Gradisnik
Summary: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling multisystemic condition characterized by impaired natural killer (NK) cell cytotoxicity. This study investigated the role of TRPM7-dependent calcium (Ca2+) influx in ME/CFS patients. The results showed that TRPM7 activation resulted in reduced Ca2+ influx in ME/CFS patients compared to healthy controls, while TRPM7 desensitization led to increased Ca2+ influx in healthy controls compared to ME/CFS patients. These findings suggest that ME/CFS may be a TRP ion channelopathy.